Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Tsuji

Showing results (571-580 of 649) with videos related to

Pageof 65
Sort By:
The Japanese Journal of Antibiotics|December 1, 1993
[Clinical studies of S-1108, a new oral cephem, in pediatric patients]T Yokoo, K Hayashi, Y Tsuji, et al.
Biochemical and Biophysical Research Communications|October 29, 1987
Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal regionG Soma, N Kitahara, Y Tsuji, et al.
The Japanese Journal of Antibiotics|August 1, 1987
[Fundamental and clinical studies of flomoxef in the pediatric field]M Yanagishima, Y Toya, M Yanai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 5, 1997
[Hepatic arterial chemotherapy for liver cancer over a period of 8 years]S Masutani, M Tatsuta, T Kawasaki, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1992
[Antiandrogen therapy of benign prostatic hypertrophy: clinical effects of allylestrenol evaluated by transrectal ultrasonographic measurement]Y Tsuji, A Ariyoshi, H Nakamura, et al.
Japanese Journal of Cancer Research : Gann|May 1, 1992
Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermiaN Yamauchi, N Watanabe, M Maeda, et al.
Leukemia Research|April 28, 2000
Qualitative and quantitative characterization of Fas (CD95) expression and its role in primary human acute leukemia cellsQ Li, K Tsuruda, K Sugahara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1995
[Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report]Y Tsuji, H Yoshihito, T Nakamura, et al.
Pancreas|November 1, 1996
Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cellsN Watanabe, N Tsuji, Y Tsuji, et al.
Japanese Journal of Cancer Research : Gann|January 1, 1993
A cancer-reactive human monoclonal antibody derived from a colonic cancer patient treated with local immunotherapyT Yagyu, T Monden, M Baba, et al.
Pageof 65

Showing results (571-580 of 649) with videos related to

Sort By:
Pageof 65
The Japanese Journal of Antibiotics|December 1, 1993
[Clinical studies of S-1108, a new oral cephem, in pediatric patients]T Yokoo, K Hayashi, Y Tsuji, et al.
Biochemical and Biophysical Research Communications|October 29, 1987
Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal regionG Soma, N Kitahara, Y Tsuji, et al.
The Japanese Journal of Antibiotics|August 1, 1987
[Fundamental and clinical studies of flomoxef in the pediatric field]M Yanagishima, Y Toya, M Yanai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 5, 1997
[Hepatic arterial chemotherapy for liver cancer over a period of 8 years]S Masutani, M Tatsuta, T Kawasaki, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 1, 1992
[Antiandrogen therapy of benign prostatic hypertrophy: clinical effects of allylestrenol evaluated by transrectal ultrasonographic measurement]Y Tsuji, A Ariyoshi, H Nakamura, et al.
Japanese Journal of Cancer Research : Gann|May 1, 1992
Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermiaN Yamauchi, N Watanabe, M Maeda, et al.
Leukemia Research|April 28, 2000
Qualitative and quantitative characterization of Fas (CD95) expression and its role in primary human acute leukemia cellsQ Li, K Tsuruda, K Sugahara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1995
[Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report]Y Tsuji, H Yoshihito, T Nakamura, et al.
Pancreas|November 1, 1996
Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cellsN Watanabe, N Tsuji, Y Tsuji, et al.
Japanese Journal of Cancer Research : Gann|January 1, 1993
A cancer-reactive human monoclonal antibody derived from a colonic cancer patient treated with local immunotherapyT Yagyu, T Monden, M Baba, et al.
Pageof 65